SYSTEMATIC LITERATURE REVIEW ON CLINICAL EFFICACY AND SAFETY OF ALOGLIPTIN IN COMPARISON WITH VILDAGLIPTIN, LINAGLIPTIN, SAXAGLIPTIN AND SITAGLIPTIN IN ADULT PATIENTS WITH TYPE 2 DIABETES MELLITUS

Type 2 diabetes mellitus (T2DM) is one the socially important diseases in the Russian Federation (RF). Dipeptidyl peptidase-4 (DPP-4) inhibitors alogliptin, vildagliptin, linagliptin, saxagliptin and sitagliptin are registered in the RF and included in both russian and international modern guideline...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Georgii Rubenovich Khachatryan, Vladislav Sergeevich Dombrovskii
Formato: Artigo
Idioma:Russo
Publicado em: IRBIS LLC 2015-09-01
Colecção:Фармакоэкономика
Assuntos:
type 2 diabetes mellitus
dipeptidyl peptidase-4 inhibitors
alogliptin
vildagliptin
linagliptin
saxagliptin
sitagliptin
clinical efficacy
clinical safety
systematic literature review
indirect comparison
Acesso em linha:https://www.pharmacoeconomics.ru/jour/article/view/105
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados